I. Gorin

1.6k total citations
39 papers, 1.1k citations indexed

About

I. Gorin is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, I. Gorin has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 13 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in I. Gorin's work include Viral-associated cancers and disorders (11 papers), Parvovirus B19 Infection Studies (7 papers) and Histiocytic Disorders and Treatments (6 papers). I. Gorin is often cited by papers focused on Viral-associated cancers and disorders (11 papers), Parvovirus B19 Infection Studies (7 papers) and Histiocytic Disorders and Treatments (6 papers). I. Gorin collaborates with scholars based in France, Austria and Switzerland. I. Gorin's co-authors include N. Dupin, J P Escande, Vincent Cálvez, Marc Grandadam, J.-M. Huraux, M Leibowitch, S. Havard, F Lamy, Henri Agut and Jean‐François Deleuze and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

I. Gorin

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Gorin France 17 745 358 339 267 247 39 1.1k
J P Escande France 13 602 0.8× 249 0.7× 268 0.8× 188 0.7× 195 0.8× 31 781
Edgardo Reyes Mexico 17 326 0.4× 156 0.4× 160 0.5× 268 1.0× 99 0.4× 40 846
U. Prasad Malaysia 19 1.2k 1.7× 372 1.0× 270 0.8× 343 1.3× 199 0.8× 42 1.6k
M Nalesnik United States 18 894 1.2× 244 0.7× 596 1.8× 378 1.4× 47 0.2× 28 1.9k
L. Brooks United Kingdom 12 536 0.7× 226 0.6× 163 0.5× 195 0.7× 98 0.4× 21 702
Marjorie Bernstein-Singer United States 11 430 0.6× 89 0.2× 207 0.6× 257 1.0× 88 0.4× 14 860
HD Foss Germany 10 432 0.6× 122 0.3× 194 0.6× 481 1.8× 29 0.1× 18 972
F. Ameglio Italy 24 192 0.3× 184 0.5× 246 0.7× 266 1.0× 129 0.5× 65 1.4k
Marie‐Claude Crevon France 18 197 0.3× 113 0.3× 223 0.7× 125 0.5× 112 0.5× 37 1.2k
Ellen G. van Lochem Netherlands 16 201 0.3× 110 0.3× 222 0.7× 213 0.8× 55 0.2× 27 1.1k

Countries citing papers authored by I. Gorin

Since Specialization
Citations

This map shows the geographic impact of I. Gorin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Gorin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Gorin more than expected).

Fields of papers citing papers by I. Gorin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Gorin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Gorin. The network helps show where I. Gorin may publish in the future.

Co-authorship network of co-authors of I. Gorin

This figure shows the co-authorship network connecting the top 25 collaborators of I. Gorin. A scholar is included among the top collaborators of I. Gorin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Gorin. I. Gorin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boussemart, Lise, S Jacobelli, Frédéric Batteux, et al.. (2010). Autoimmune Bullous Skin Diseases Occurring under Anti-Tumor Necrosis Factor Therapy: Two Case Reports. Dermatology. 221(3). 201–205. 52 indexed citations
2.
Maubec, E., F. Boitier, Pierre Duvillard, et al.. (2010). Mélanomes chez des patients séropositifs pour le VIH : 14 cas. Annales de Dermatologie et de Vénéréologie. 137(12). 769–774. 1 indexed citations
3.
Soufir, Nadem, J Lacapère, S. Régnier, et al.. (2008). Xeroderma pigmentosum group C in a French Caucasian patient with multiple melanoma and unusual long-term survival. British Journal of Dermatology. 159(4). 968–973. 6 indexed citations
4.
Martinez, Valérie, Éric Caumes, Laëtitia Gambotti, et al.. (2006). Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy. British Journal of Cancer. 94(7). 1000–1006. 58 indexed citations
5.
Soufir, Nadem, Bénédicte Gérard, Alexis Brice, et al.. (2006). PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study. British Journal of Cancer. 95(4). 548–553. 45 indexed citations
6.
Tréluyer, Jean‐Marc, Jérôme Dimet, I. Gorin, et al.. (2003). High concentrations of nelfinavir as an independent risk factor for lipodystrophy in HIV‐infected patients. Clinical Pharmacology & Therapeutics. 73(2). 1 indexed citations
7.
Gorin, I., et al.. (2001). [Androgenic alopecia revealing an androgen secreting ovarian tumor].. PubMed. 128(11). 1241–4. 5 indexed citations
8.
Salmon‐Céron, Dominique, Jean‐François Deleuze, Joël Coste, et al.. (2000). [Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients].. PubMed. 151(4). 297–302. 7 indexed citations
9.
Dupin, N., I. Gorin, Vincent Cálvez, et al.. (1999). The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma. British Journal of Dermatology. 140(5). 875–881. 48 indexed citations
10.
Montero‐Julian, Félix A., Hervé Brailly, I Joyeux, et al.. (1997). Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.. PubMed. 3(8). 1443–51. 33 indexed citations
12.
Dupin, N., Nicolás Franck, Vincent Cálvez, et al.. (1997). Lack of evidence of human herpesvirus 8 DNA sequences in HIV-negative patients with various lymphoproliferative disorders of the skin. British Journal of Dermatology. 136(6). 827–830. 14 indexed citations
13.
Dupin, N., et al.. (1995). Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease.. PubMed. 333(12). 798; author reply 798–9. 66 indexed citations
14.
Dupin, N., Marc Grandadam, Vincent Cálvez, et al.. (1995). Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. The Lancet. 345(8952). 761–762. 300 indexed citations
15.
Raynaud, Florence I., et al.. (1993). Rapid Effect of Treatment of Psoriatic Erythrocytes with the Synthetic Retinoid Acitretin to Increase 8-Azido Cyclic AMP Bindings to the RI Regulatory Subunit. Journal of Investigative Dermatology. 100(1). 77–81. 11 indexed citations
16.
Lassoued, Kaı̈ss, et al.. (1991). AIDS-associated Kaposiʼs sarcoma in female patients. AIDS. 5(7). 877–880. 24 indexed citations
17.
Gorin, I., et al.. (1990). Thalidomide may cure AIDS ulcers.. PubMed. 86(24). 10–10. 3 indexed citations
18.
Gorin, I., et al.. (1989). Successful treatment of the pruritus of human immunodeficiency virus infection and acquired immunodeficiency syndrome with psoralens plus ultraviolet A therapy. Journal of the American Academy of Dermatology. 20(3). 511–513. 29 indexed citations
19.
Monsuez, Jean-Jacques, Evlin L. Kinney, Daniel Vittecoq, et al.. (1988). Comparison among acquired immune deficiency syndrome patients with and without clinical evidence of cardiac disease. The American Journal of Cardiology. 62(17). 1311–1313. 50 indexed citations
20.
Jeanneau, C., et al.. (1987). Absence of functional activity of tissue plasminogen activator in patients with severe forms of von Willebrand's disease. British Journal of Haematology. 67(1). 79–88. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026